Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Small intestinal bacterial overgrowth

From Wikipedia, the free encyclopedia
(Redirected fromSmall bowel bacterial overgrowth syndrome)
Medical condition
Small intestinal bacterial overgrowth
Other namesbacterial overgrowth, small bowel bacterial overgrowth syndrome (SBBOS)
Theileocecal valve prevents reflux of bacteria from the colon into the small bowel. Resection of the valve can lead to bacterial overgrowth.
SpecialtyGastroenterology Edit this on Wikidata

Small intestinal bacterial overgrowth (SIBO), also termedbacterial overgrowth, orsmall bowel bacterial overgrowth syndrome (SBBOS), is a disorder of excessivebacterial growth in thesmall intestine. Unlike thecolon (or large bowel), which is rich with bacteria, the small intestine usually has fewer than 100,000 organisms per millilitre.[1] Patients with SIBO typically develop symptoms which may includenausea,bloating,vomiting,diarrhea,malnutrition,weight loss, andmalabsorption[2] by various mechanisms.

Thediagnosis of SIBO is made by several techniques, with thegold standard[3] being anaspirate from thejejunum that grows more than 105bacteria per millilitre.Risk factors for the development of SIBO include dysmotility;anatomical disturbances in the bowel, includingfistulae,diverticula andblind loops created after surgery, and resection of theileo-cecal valve;gastroenteritis-induced alterations to the small intestine; and the use of certain medications, includingproton pump inhibitors.

SIBO is treated with anelemental diet orantibiotics, which may be given cyclically to prevent tolerance to the antibiotics, sometimes followed byprokinetic drugs to prevent recurrence if dysmotility is a suspected cause.

Definition

[edit]

SIBO may be defined as an increased number of bacteria measured via exhaled hydrogen and/or methane gas following the ingestion ofglucose, or via analysis of small bowel aspirate fluid.[3] Nevertheless, as of 2020, the definition of SIBO as a clinical entity lacks precision and consistency; it is a term generally applied to a clinical disorder where symptoms, clinical signs, and/or laboratory abnormalities are attributed to changes in the numbers of bacteria or the composition of the bacterial population in the small intestine.[4] The main obstacle to accurately defining SIBO is limited understanding of the normal intestinal microbial population. Future advances in sampling technology and techniques for counting bacterial populations and their metabolites should provide much-needed clarity.[4]

Methane-dominant SIBO

[edit]

ThearchaeonMethanobrevibacter smithii has been associated with symptoms of SIBO, which result in a positive methane breath test.[5] In addition to the archaeon, a few bacteria can also produce methane, such as members of theClostridium andBacteroides genus. Production of methane, therefore, may not be bacterial, nor limited to the small intestine, and it has been proposed that the condition should be classified as a separate 'intestinalmethanogen overgrowth' (IMO).[5]

Signs and symptoms

[edit]
Deficiency of vitamin B12 can occur in SIBO.[4]

Symptoms traditionally linked to SIBO includebloating,diarrhea,constipation, and abdominal pain/discomfort.Steatorrhea may be seen in more severe cases.[4]

SIBO can cause a variety ofsymptoms, many of which are also found in other conditions, making thediagnosis challenging at times.[4] Many of the symptoms are due tomalabsorption of nutrients due to the effects of bacteria, which either metabolize nutrients or cause inflammation of the small bowel, impairing absorption. The symptoms of SIBO includenausea,flatus,[6]constipation,[7] bloating, abdominal distension, abdominal pain or discomfort, diarrhea,[8] fatigue, and weakness. SIBO also causes an increasedpermeability of the small intestine.[9] Some patients may lose weight. Children with SIBO may developmalnutrition and have difficulty attainingproper growth.Steatorrhea, a sticky type of diarrhea wherefat is not properly absorbed and spills into the stool, may also occur.[6]

People with long-term SIBO may developcomplications as a result of malabsorption of nutrients.[10] Blood tests may show increased level offolate (vitamin B9).[4] Less commonly, there may bevitamin B12 deficiency or other nutritional deficiencies.[4] The combination of elevated folate and low vitamin B12 is unusual.[4]Anemia may occur from a variety of mechanisms, as many of the nutrients involved in the production ofred blood cells are absorbed in the affected small bowel.Iron is absorbed in the more proximal parts of the small bowel, theduodenum andjejunum, and patients with malabsorption of iron can develop amicrocytic anemia, with small red blood cells. Vitamin B12 is absorbed in the last part of the small bowel, theileum, and patients who have malabsorption of vitamin B12 can develop amegaloblastic anemia with large red blood cells.[6]

Causes

[edit]
E. coli, shown in this electron micrograph, is commonly isolated in patients with SIBO

Certain people are more predisposed to the development of SIBO because of certain risk factors. These factors can be grouped into four categories: (1)motility disorders, impaired movement of the small bowel, or anatomical changes that lead to stasis (a state in which the normal flow of a body liquid stops); (2) disorders of theimmune system; (3) interference with the production of proteolytic enzymes, gastric acid, or bile; and (4) conditions that cause more bacteria from thecolon to enter thesmall bowel.[4]

Absence or impairment of themigrating motor complex (MMC), a cyclical motility pattern in the small intestine, and phase III of the MMC in particular, is associated with the development of SIBO.[11] Problems with motility may either be diffuse or localized to particular areas.

MMC impairment may be a result of post-infectious IBS, drug use, orintestinal pseudo-obstruction among other causes.[12] There is an overlap in findings betweentropical sprue, post-infectious IBS and SIBO in the pathophysiology of the three conditions and also SIBO can similarly sometimes be triggered by an acute gastrointestinal infection.[13][14][15] As of 2020, there is still controversy about the role of SIBO in the pathogenesis of common functional symptoms such as those considered to be components of IBS.[4] Diseases likescleroderma[16] cause diffuse slowing of the bowel, leading to increased bacterial concentrations. More commonly, the small bowel may have anatomical problems, such as out-pouchings known asdiverticula that can cause bacteria to accumulate.[17] After surgery involving thestomach andduodenum (most commonly withBillroth II antrectomy), ablind loop may be formed, leading to stasis of flow of intestinal contents. This can cause overgrowth, and is termedblind loop syndrome.[18]

Systemic or metabolic disorders may lead to conditions allowing SIBO as well. For example, diabetes can cause intestinal neuropathy,pancreatitis, leading topancreatic insufficiency can impair digestive enzyme production, and bile may be affected as part ofcirrhosis of the liver.[19] The use ofproton pump inhibitors, a class of medication used to reduce stomach acid, is associated with an increased risk of developing SIBO.[20]

Finally, abnormal connections between thebacteria-rich colon and the small bowel can increase the bacterial load in the small bowel. Patients withCrohn's disease or other diseases of theileum may require surgery that removes theileocecal valve connecting the small and large bowel; this leads to an increased reflux of bacteria into the small bowel.[citation needed] Afterbariatric surgery for obesity, connections between the stomach and theileum can be formed, which may increase bacterial load in the small bowel.[21]

Related conditions

[edit]

In recent years, several proposed links between SIBO and other disorders have been made. Usually, such research usesbreath testing as an indirect investigation for SIBO.

Irritable bowel syndrome

[edit]

Some studies reported that up to 80% of patients withirritable bowel syndrome (IBS) have SIBO (using thehydrogen breath test). IBS-D is associated with elevated hydrogen numbers on breath tests, while IBS-C is associated with elevated methane numbers on breath tests.[22] Subsequent studies demonstrated statistically significant reduction in IBS symptoms following therapy for SIBO.[23][22][7]

Various mechanisms are involved in the development of diarrhea and IBS-D in SIBO. First, the excessive bacterial concentrations can cause direct inflammation of the small bowel cells, leading to aninflammatory diarrhea. The malabsorption oflipids,proteins, andcarbohydrates may cause poorly digestible products to enter the large bowel. This can cause anosmotic diarrhea or stimulate the colonic cells to cause asecretory diarrhea.[6]

There is a lack of consensus regarding the suggested link between IBS and SIBO. Other authors concluded that the abnormal breath results so common in IBS patients do not suggest SIBO, and state that "abnormal fermentation timing and dynamics of the breath test findings support a role for abnormal intestinal bacterial distribution in IBS."[24] There is consensus that breath tests are abnormal in IBS; however, the disagreement lies in whether this is representative of SIBO.[25]

Diagnosis

[edit]
Aspiration of bacteria from thejejunum is the gold standard for diagnosis. A bacterial load of greater than 105 bacteria per milliliter is diagnostic for SIBO.

D-xylose absorption test

[edit]

Malabsorption can be detected by a test called theD-xylose absorption test.Xylose is a sugar that does not require enzymes to be digested. TheD-xylose test involves having a patient drink a certain quantity of D-xylose, and measuring levels in theurine andblood; if there is no evidence of D-xylose in theurine andblood, it suggests that the small bowel is not absorbing properly (as opposed to problems with enzymes required for digestion).[26]

Small bowel aspirate culture

[edit]

Thegold standard for detection of SIBO isaspiration andculture of fluid from the jejunum. More than 105colony-forming units (more than 100,000 bacteria) per milliliter from the small bowel suggests SIBO.[27] The normal small bowel has less than 104 bacteria per millilitre.[citation needed] However, some experts consider aspiration of more than 103 positive if the flora is predominantly colonic-type bacteria, as these types of bacteria are considered pathological in excessive numbers in the small intestine. The reliability of aspiration in the diagnosis of SIBO has been questioned, as SIBO can be patchy, and the reproducibility can be as low as 38%. Some doctors factor in a patient's response to treatment as part of the diagnosis.[4]

Biopsies of the small bowel in SIBO can mimicceliac disease, with partialvillous atrophy.

Breath tests

[edit]

Breath tests for SIBO are either based on bacterial metabolism ofcarbohydrates tohydrogen,methane, orhydrogen sulfide; or based on the detection of by-products of the digestion of carbohydrates that are not usually metabolized. Thehydrogen breath test involves having the patient fast for a minimum of 12 hours, then having them drink a substrate, usually glucose orlactulose, then measuring expired hydrogen and methane concentrations typically over several hours. It compares well to jejunal aspirates in making the diagnosis of SIBO.[citation needed]Carbon-13 (13C) andcarbon-14 (14C) based tests have also been developed based on the bacterial metabolism of D-xylose. Increased bacterial concentrations are also involved in the deconjugation of bile acids. Theglycocholic acid breath test involves the administration of the bile acid14C glycocholic acid, and the detection of14CO2, which would be elevated in SIBO.[citation needed]

Breath tests may be an imperfect test for SIBO. In some people, methanogens may reside in the mouth, as evidenced by reductions in breath methane levels following mouthwash withchlorhexidine.[28] This may affect results from hydrogen-methane breath testing. Breath tests give multiplefalse positives (a positive test result when in reality the person does not have the condition).[29] On the other hand, breath tests are commonly used because they are non invasive and not expensive.[27]

Other diagnostic methods

[edit]

Some physicians suggest that if the suspicion of SIBO is high enough, the best diagnostic test is a trial of treatment. If the symptoms improve, an empiric diagnosis of SIBO can be made.[30]

There is insufficient evidence to support the use of inflammatory markers, such asfecal calprotectin, to detect SIBO.[4]

Treatment

[edit]

Treatment strategies should focus on identifying and correcting the root causes, resolving nutritional deficiencies, and administering antibiotics. This is especially important for patients with indigestion and malabsorption.[4] Whether antibiotics should be a first-line treatment is debated. Some experts recommendprobiotics as first-line therapy, with antibiotics reserved as a second-line treatment for more severe cases of SIBO.Prokinetic drugs are other options, but human research is limited.[31][32][unreliable source?] A variety of antibiotics, includingtetracycline,amoxicillin-clavulanate,metronidazole,neomycin,cephalexin andtrimethoprim-sulfamethoxazole have been used; however, the best evidence is for the use ofrifaximin, a poorly-absorbed antibiotic.[2] Although IBS has been shown to respond to the treatment of poorly-absorbed antibiotics, there is limited evidence on the effectiveness of such treatment in cases of SIBO, and as of 2020, randomized controlled trials are still needed to confirm the eradicating effect of such treatment in SIBO.[4]A course of one week of antibiotics is usually sufficient to treat the condition. However, if the condition recurs, antibiotics can be given cyclically to prevent tolerance. For example, antibiotics may be given for a week, followed by three weeks off antibiotics, followed by another week of treatment. Alternatively, the choice of antibiotic used can be cycled.[30] There is still limited data to guide the clinician in developing antibiotic strategies for SIBO. Therapy remains, for the most part, empiric. However, concerns exist about the potential risks of long-term broad-spectrum antibiotic therapy.[4]

Probiotics are bacterial preparations that alter the bacterial flora in the bowel to cause a beneficial effect. Animal research has demonstrated that probiotics have barrier-enhancing, antibacterial, immune-modulating, and anti-inflammatory effects, which may have a positive effect in the management of SIBO in humans.[4][failed verification]Lactobacillus casei is effective in improving breath hydrogen scores after six weeks of treatment, presumably by suppressing levels of a small intestinal SIBO of fermenting bacteria.[citation needed]Lactobacillus plantarum,Lactobacillus acidophilus, andLactobacillus casei have all demonstrated effectiveness in the treatment and management of SIBO.[citation needed] Conversely,Lactobacillus fermentum andSaccharomyces boulardii have been found to be ineffective.[4][failed verification] A combination ofLactobacillus plantarum andLactobacillus rhamnosus is effective in suppressing SIBO of abnormal gas producing organisms in the small intestine.[33][non-primary source needed]

A combination of probiotic strains has been found to produce better results than therapy with the antibiotic drugmetronidazole.[34][non-primary source needed]

Anelemental diet has been shown to be highly effective for eliminating SIBO with a two-week diet demonstrating 73% efficacy in normalizing breath test levels.[35][36][37] An elemental diet works via providing nutrition for the individual while depriving the bacteria of a food source.[38] Additional treatment options include the use ofprokinetic drugs such as5-HT4 receptor agonists ormotilin agonists to extend the SIBO free period after treatment with an elemental diet or antibiotics.[39][non-primary source needed] A diet void of certain foods that feed the bacteria can help alleviate the symptoms.[40] For example, if the symptoms are caused by SIBO feeding on indigestible carbohydrate rich foods, following alow-FODMAP diet may help.[40][non-primary source needed]

Epidemiology

[edit]

According to breath testing, SIBO may be present in 34% of people with gastrointestinal symptoms.[41] SIBO affects males and females in equal proportion. Race does not affect the risk of SIBO.[41]

See also

[edit]

References

[edit]
  1. ^Finegold SM (June 1969)."Intestinal Bacteria — The Role They Play in Normal Physiology, Pathologic Physiology, and Infection".Western Journal of Medicine.110 (6): 455 –4 59.PMC 1503548.PMID 5789139.
  2. ^abBures J, Cyrany J, Kohoutova D, Förstl M, Rejchrt S, Kvetina J, et al. (June 2010)."Small intestinal bacterial overgrowth syndrome".World Journal of Gastroenterology.16 (24):2978–90.doi:10.3748/wjg.v16.i24.2978.PMC 2890937.PMID 20572300.
  3. ^abGhoshal UC, Ghoshal U, Das K, Misra A (January–February 2006). "Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time".Indian Journal of Gastroenterology.25 (1):6–10.PMID 16567886.
  4. ^abcdefghijklmnopqQuigley E, Murray J, Pimentel M (October 2020)."AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review".Gastroenterology.159 (4):1526–1532.doi:10.1053/j.gastro.2020.06.090.PMID 32679220.
  5. ^abTakakura, Will; Pimentel, Mark (2020-07-10)."Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome – An Update".Frontiers in Psychiatry.11 664.doi:10.3389/fpsyt.2020.00664.ISSN 1664-0640.PMC 7366247.PMID 32754068.
  6. ^abcdKirsch M (March 1990). "Bacterial overgrowth".The American Journal of Gastroenterology.85 (3):231–7.PMID 2178395.
  7. ^abLin HC (August 2004)."Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome".JAMA.292 (7):852–8.doi:10.1001/jama.292.7.852.PMID 15316000.
  8. ^Sachdev AH, Pimentel M (September 2013)."Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance".Therapeutic Advances in Chronic Disease.4 (5):223–31.doi:10.1177/2040622313496126.PMC 3752184.PMID 23997926.
  9. ^Lykova EA, Bondarenko VM, Parfenov AI, Matsulevich TV (2005). "[Bacterial overgrowth syndrome in the small intestine: pathogenesis, clinical significance and therapy tactics]".Eksperimental'naia i Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology (in Russian) (6):51–7, 113.PMID 17378388.
  10. ^Ensari A (21 Aug 2014)."The Malabsorption Syndrome and Its Causes and Consequences".Pathobiology of Human Disease:1266–1287.doi:10.1016/B978-0-12-386456-7.03804-1.ISBN 9780123864574.PMC 7149679.
  11. ^Deloose E, Janssen P, Depoortere I, Tack J (March 2012). "The migrating motor complex: control mechanisms and its role in health and disease".Nature Reviews. Gastroenterology & Hepatology.9 (5):271–85.doi:10.1038/nrgastro.2012.57.PMID 22450306.S2CID 22753804.
  12. ^Pimentel M (31 July 2018). Lamont JT, Grover S (eds.)."Small intestinal bacterial overgrowth: Etiology and pathogenesis".UpToDate.Archived from the original on 2019-12-12. Retrieved2019-12-11.
  13. ^Ghoshal UC, Park H, Gwee KA (February 2010)."Bugs and irritable bowel syndrome: The good, the bad and the ugly".Journal of Gastroenterology and Hepatology.25 (2):244–51.doi:10.1111/j.1440-1746.2009.06133.x.PMID 20074148.S2CID 22023086.
  14. ^Othman M, Agüero R, Lin HC (January 2008)."Alterations in intestinal microbial flora and human disease".Current Opinion in Gastroenterology.24 (1):11–6.doi:10.1097/MOG.0b013e3282f2b0d7.PMID 18043226.S2CID 20329070.Archived from the original on 2021-04-22. Retrieved2014-02-01.
  15. ^Song KH, Jung HK, Kim HJ, Koo HS, Kwon YH, Shin HD, et al. (April 2018)."Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition".Journal of Neurogastroenterology and Motility.24 (2):197–215.doi:10.5056/jnm17145.PMC 5885719.PMID 29605976.
  16. ^Rose S, Young MA, Reynolds JC (September 1998). "Gastrointestinal manifestations of scleroderma".Gastroenterology Clinics of North America.27 (3):563–94.doi:10.1016/S0889-8553(05)70021-2.PMID 9891698.
  17. ^Kongara KR, Soffer EE (January 2000). "Intestinal motility in small bowel diverticulosis: a case report and review of the literature".Journal of Clinical Gastroenterology.30 (1):84–6.doi:10.1097/00004836-200001000-00017.PMID 10636218.
  18. ^"Blind Loop Syndrome".www.hopkinsmedicine.org. 2019-11-19.Archived from the original on 2023-01-03. Retrieved2023-01-03.
  19. ^Dukowicz AC, Lacy BE, Levine GM (February 2007)."Small intestinal bacterial overgrowth: a comprehensive review".Gastroenterology & Hepatology.3 (2):112–22.PMC 3099351.PMID 21960820.
  20. ^Lo WK, Chan WW (May 2013). "Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis".Clinical Gastroenterology and Hepatology.11 (5):483–90.doi:10.1016/j.cgh.2012.12.011.PMID 23270866.
  21. ^Abell TL, Minocha A (April 2006). "Gastrointestinal complications of bariatric surgery: diagnosis and therapy".The American Journal of the Medical Sciences.331 (4):214–8.doi:10.1097/00000441-200604000-00008.PMID 16617237.S2CID 25920218.
  22. ^abReddymasu SC, Sostarich S, McCallum RW (February 2010)."Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?".BMC Gastroenterol.10 23.doi:10.1186/1471-230X-10-23.PMC 2838757.PMID 20175924.
  23. ^Pimentel M (2006).A new IBS solution: bacteria, the missing link in treating irritable bowel syndrome. Sherman Oaks, CA: Health Point Press.ISBN 978-0977435609.
  24. ^Shah ED, Basseri RJ, Chong K, Pimentel M (September 2010). "Abnormal breath testing in IBS: a meta-analysis".Digestive Diseases and Sciences.55 (9):2441–9.doi:10.1007/s10620-010-1276-4.PMID 20467896.S2CID 38690372.
  25. ^Ford AC, Spiegel BM, Talley NJ, Moayyedi P (December 2009)."Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis".Clinical Gastroenterology and Hepatology.7 (12):1279–86.doi:10.1016/j.cgh.2009.06.031.PMID 19602448.S2CID 2637076.
  26. ^Craig RM, Atkinson AJ (July 1988). "D-xylose testing: a review".Gastroenterology.95 (1):223–31.doi:10.1016/0016-5085(88)90318-6.PMID 3286361.
  27. ^abZafar, Hammad; Jimenez, Brenda; Schneider, Alison (2023-11-01). "Small intestinal bacterial overgrowth: current update".Current Opinion in Gastroenterology.39 (6):522–528.doi:10.1097/MOG.0000000000000971.ISSN 1531-7056.PMID 37751393.
  28. ^Erdrich S, Tan Edwin CK, Hawrelak JA, Myers SP, Harnett JE (2021)."Hydrogen–methane breath testing results influenced by oral hygiene".Scientific Reports.11 (26) 26.doi:10.1038/s41598-020-79554-x.PMC 7794545.PMID 33420116.Archived from the original on 2022-07-29. Retrieved2021-05-22.
  29. ^Simrén M, Stotzer PO (March 2006)."Use and abuse of hydrogen breath tests".Gut.55 (3):297–303.doi:10.1136/gut.2005.075127.PMC 1856094.PMID 16474100.
  30. ^abSingh VV, Toskes PP (February 2004). "Small Bowel Bacterial Overgrowth: Presentation, Diagnosis, and Treatment".Current Treatment Options in Gastroenterology.7 (1):19–28.doi:10.1007/s11938-004-0022-4.PMID 14723835.S2CID 10045342.
  31. ^Goulet O, Joly F (September 2010). "[Intestinal microbiota in short bowel syndrome]".Gastroenterologie Clinique et Biologique.34 (Suppl 1): S37-43.doi:10.1016/S0399-8320(10)70019-1.PMID 20889003.
  32. ^Bondarenko VM, Lykova EA, Matsulevich TV (2006). "[Microecological aspects of small intestinal bacterial overgrowth syndrome]".Zhurnal Mikrobiologii, Epidemiologii, I Immunobiologii (in Russian) (6):57–63.PMID 17163142.
  33. ^Rolfe RD (February 2000)."The role of probiotic cultures in the control of gastrointestinal health".The Journal of Nutrition.130 (2S Suppl):396S –402S.doi:10.1093/jn/130.2.396S.PMID 10721914.
  34. ^Bested AC, Logan AC, Selhub EM (March 2013)."Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III – convergence toward clinical trials".Gut Pathogens.5 (1) 4.doi:10.1186/1757-4749-5-4.PMC 3605358.PMID 23497650.
  35. ^Rezaie, Ali; Chang, Bianca W.; Germano, Juliana de Freitas; Leite, Gabriela; Mathur, Ruchi; Houser, Krystyna; Hosseini, Ava; Brimberry, Daniel; Rashid, Mohamad; Mehravar, Sepideh; Villanueva-Millan, Maria Jesus; Sanchez, Maritza; Weitsman, Stacy; Fajardo, Cristina M.; Rivera, Ignacio G. (2025-04-04)."Effect, Tolerability, and Safety of Exclusive Palatable Elemental Diet in Patients with Intestinal Microbial Overgrowth".Clinical Gastroenterology and Hepatology.23 (12): 2306–2317.e7.doi:10.1016/j.cgh.2025.03.002.ISSN 1542-3565.PMID 40189034.
  36. ^Rezaie A, Pimentel M, Rao SS (February 2016). "How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach".Current Gastroenterology Reports.18 (2) 8.doi:10.1007/s11894-015-0482-9.PMID 26780631.S2CID 207329305.
  37. ^Krajicek EJ, Hansel SL (December 2016)."Small Intestinal Bacterial Overgrowth: A Primary Care Review".Mayo Clinic Proceedings.91 (12):1828–1833.doi:10.1016/j.mayocp.2016.07.025.PMID 27916156.
  38. ^Buchman A (2006).Clinical nutrition in gastrointestinal disease. Thorofare, NJ: SLACK. p. 277.ISBN 978-1-55642-697-1.Archived from the original on 2023-01-11. Retrieved2016-05-18.
  39. ^Talley NJ, Kane S, Wallace MB (2010).Practical Gastroenterology and Hepatology: Small and Large Intestine and Pancreas. Chichester, West Sussex: Wiley-Blackwell.ISBN 978-1-4051-8274-4.Archived from the original on 2023-01-11. Retrieved2016-05-18.
  40. ^abGibson PR, Barrett JS (2010). "The concept of small intestinal bacterial overgrowth in relation to functional gastrointestinal disorders".Nutrition.26 (11–12):1038–43.doi:10.1016/j.nut.2010.01.005.PMID 20418060.
  41. ^abEfremova, Irina; Maslennikov, Roman; Poluektova, Elena; Vasilieva, Ekaterina; Zharikov, Yury; Suslov, Andrey; Letyagina, Yana; Kozlov, Evgenii; Levshina, Anna; Ivashkin, Vladimir (2023-06-14)."Epidemiology of small intestinal bacterial overgrowth".World Journal of Gastroenterology.29 (22):3400–3421.doi:10.3748/wjg.v29.i22.3400.ISSN 2219-2840.PMC 10303511.PMID 37389240.
Classification
External resources
Diseases of thehuman digestive system
Upper GI tract
Esophagus
Stomach
Lower GI tract
Enteropathy
Small intestine
(Duodenum/Jejunum/Ileum)
Large intestine
(Appendix/Colon)
Large and/or small
Rectum
Anal canal
GI bleeding
Accessory
Liver
Gallbladder
Bile duct/
Otherbiliary tree
Pancreatic
Other
Hernia
Peritoneal
Management
Related topics
Retrieved from "https://en.wikipedia.org/w/index.php?title=Small_intestinal_bacterial_overgrowth&oldid=1320230690"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp